The dual role of LBP and CD14 in response to Gram-negative bacteria or Gram-negative compounds

Abstract

Innate immunity initiates protection of the host organism against invasion of micro-organisms by specific recognition mechanisms. This article reviews the dual role of LBP/CD14 in innate immunity, focusing mostly on experiments performed in mice by the authors. LPS induces uncontrolled pro-inflammatory response that kills the host and is LBP- and CD14-dependent, as neutralization of LBP and CD14 prevents lethal shock. However, surprisingly, the synthetic Pam3CysSerLys4 bacterial lipoprotein from Escherichia coli (BLP), which is well tolerated in mice, kills the mice upon LBP or CD14 blockade. Furthermore, after blockade of LBP and CD14, the mice succumb to a challenge with virulent Klebsiella pneumoniae or Salmonella typhimurium. Therefore, host responses to Gram-negative bacteria are not identical to that of LPS or BLP. When the host is in the presence of virulent Gram-negative bacteria, the invading pathogens must be held in check by the innate immune system until a specific immune response is mounted. Under these conditions, LBP, CD14, and likely Toll-like receptors (TLRs) are a prerequisite to trigger a pro-inflammatory response of macrophages, which is crucial for keeping an infection under control. These studies indicate that we are very far from understanding how the innate system works and more work needs to be done concerning LBP, CD14 or TLRs. Therefore, caution should be the rule about the use of therapeutic approaches to block the pro-inflammatory response in Gram-negative infections.

References

Schumann RR , Leong SR , Flaggs GW et al. Structure and function of lipopolysaccharide binding protein . Science 1990; 249: 1429—1431.

Wright SD , Ramos RA , Tobias PS , Ulevitch RJ , Mathison JC CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990; 249: 1431—1433.

Gallay P. , Heumann D. , Le Roy D. , B arras C. , Glauser MP Lipopolysaccharide-binding protein as a major plasma protein responsible for endotoxemic shock. Proc Natl Acad Sci USA 1993; 90: 9935—9938.

Le Roy D. , Di Padova F. , Tees R. et al. Monoclonal antibodies to murine lipopolysaccharide (LPS)-binding protein (LBP) protect mice from lethal endotoxemia by blocking either the binding of LPS to LBP or the presentation of LPS/LBP complexes to CD14. J Immunol 1999; 162: 7454—7460.

Jack RS , Fan XL , Bernheiden M. et al. Lipopolysaccharide-binding protein is required to combat a Gram-negative bacterial infection. Nature 1997; 389: 742—745.

Haziot A. , Ferrero E. , Köntgen F. et al. Resistance to endotoxin shock and reduced dissemination of Gram-negative bacteria in CD14-deficient mice. Immunity 1996; 4: 407—414.

Schimke J. , Mathison J. , Morgiewicz J. , Ulevitch RJ Anti-CD 14 mAb treatment provides therapeutic benefit after exposure to endotoxin . Proc Natl Acad Sci USA 1998; 95: 13875—13880.

Leturcq D. , Moriarty AM , Talbott G. , Winn RK , Martin TR , Ulevitch RJ Antibodies against CD14 protect primates from endotoxin-induced shock. J Clin Invest 1996; 98: 1533—1538.

Aliprantis AO , Yang RB , Mark MR et al. Cell activation and apoptosis by bacterial lipoproteins through Toll-like receptor-2. Science 1999; 285: 736—739.

10.

Wooten RM , Morrison TB , Weis JH , Wright SD , Thieringer R. , Weis JJ The role of CD14 in signaling mediated by outer membrane lipoproteins of Borrelia burgdorferi. J Immunol 1998; 160: 5485—5492.

11.

Giambartolomei GH , Dennis VA , Lasater BL , Philipp MT Induction of pro- and anti-inflammatory cytokines by Borrelia burgdorferi lipoproteins in monocytes is mediated by CD14. Infect Immun 1999; 67: 140—147.

12.

Soler-Rodriguez AM , Zhang H. , Lichenstein H. et al. Neutrophil activation by bacterial lipoprotein versus lipopolysaccharide: differential requirements for serum and CD14. J Immunol 2000; 164: 2674—2683.

13.

Hirschfeld M. , Ma Y. , Weis JH , Vogel SN , Weis JJ Repurification of lipopolysaccharide eliminates signaling through both human and murine Toll-like receptor 2. J Immunol 2000; 165: 618—622.

14.

Werts C. , Tapping RI , Mathison JC et al. Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism. Nat Immunol 2001; 2: 346—352.

15.

Bainbridge BW , Darveau RP Porphyromonas gingivalis lipopolysaccharide: an unusual pattern recognition receptor ligand for the innate host defense system. Acta Odontol Scand 2001; 59: 131—138.

16.

Pridmore AC , Wyllie DH , Adbillahi F. et al. A polysaccharide-deficient mutant of Neisseria meningitidis elicits attenuated cytokine release by human macrophages and signals via Toll-like receptor (TLR) 2 but not via TLR4/MD2. J Infect Dis 2001; 183: 89—96.

17.

Le Roy D. , Di Padova F. , Adachi Y. , Glauser MP , Calandra T. , Heumann D. Critical role of lipopolysaccharide-binding protein and CD14 in immune responses against Gram-negative bacteria. J Immunol 2001; 167: 2759—2765.

18.

Cross A. , Asher L. , Seguin M. et al. The importance of a lipopolysaccharide-initiated, cytokine-mediated host defense mechanism in mice against extraintestinal invasive Escherichia coli. J Clin Invest 1995; 96: 676—686.

19.

Rosenstreich DL , Weinblatt AC , O'Brien AD. Genetic control of resistance to infection in mice. Crit Rev Immunol 1982 ; 3: 263—230.

20.

Fierer J. , Swancutt MA , Heumann D. , Golenbock D. The role of lipopolysaccharide binding protein in resistance to Salmonella infections in mice. J Immunol 2002; 168, 6396—6403.

21.

Wenneras C. , Ave P. , Huerre M. et al. Blockade of CD14 increases Shigella-mediated invasion and tissue destruction. J Immunol 2000; 164: 3214—3221.

22.

Gegner JA , Ulevitch RJ , Tobias PS Lipopolysaccharide (LPS) signal transduction and clearance. Dual roles for LPS binding protein and membrane CD14. J Biol Chem 1995; 270: 5320—5325.